
51 - 200 funcionários
Fundada em 2004
🧬 Biotecnologia
💊 Farmacêutico
💰 $75.000.000 Post IPO equity em 2024-02
Biotechnology • Pharmaceuticals
A Liquidia é uma empresa biofarmacêutica focada no desenvolvimento de terapias inaladas para doenças cardiopulmonares raras, particularmente hipertensão arterial pulmonar (HAP) e hipertensão pulmonar associada à doença pulmonar intersticial (HP-DPI). A empresa utiliza sua tecnologia proprietária PRINT® de engenharia de partículas para criar formulações e métodos de administração exclusivos, com o objetivo de melhorar a eficácia, tolerabilidade e conveniência dos medicamentos inalados; seu pipeline inclui treprostinil inalado (produto comercial) e candidatos em estágio clínico como o L606. A Liquidia enfatiza o suporte ao paciente, o desenvolvimento clínico e o avanço de terapias para melhorar os resultados respiratórios.
🕒 Julho 27
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2004
🧬 Biotecnologia
💊 Farmacêutico
💰 $75.000.000 Post IPO equity em 2024-02
Biotechnology • Pharmaceuticals
A Liquidia é uma empresa biofarmacêutica focada no desenvolvimento de terapias inaladas para doenças cardiopulmonares raras, particularmente hipertensão arterial pulmonar (HAP) e hipertensão pulmonar associada à doença pulmonar intersticial (HP-DPI). A empresa utiliza sua tecnologia proprietária PRINT® de engenharia de partículas para criar formulações e métodos de administração exclusivos, com o objetivo de melhorar a eficácia, tolerabilidade e conveniência dos medicamentos inalados; seu pipeline inclui treprostinil inalado (produto comercial) e candidatos em estágio clínico como o L606. A Liquidia enfatiza o suporte ao paciente, o desenvolvimento clínico e o avanço de terapias para melhorar os resultados respiratórios.
• Direct Commercial new product planning and lifecycle strategy. Provide input into future product development, specifically L606 BID Treprostinil. Integrate global market insights, financial opportunity, and portfolio strategy to optimize future commercial opportunity • Shape upstream clinical development strategy for Phase III and IV studies. Translate unmet needs and financial value into endpoint/label discussions, patient population strategy, and evidence-generation plans to maximize future label strength and access potential • Participate in the annual Brand Planning process for Yutrepia, establishing positioning, core messaging, and strategic objectives across HCP, patient, and payer stakeholders • Track market intelligence for the PH landscape, monitoring market volume and share trends, competitor pipelines. Synthesize insights into decision-ready recommendations • Perform market research to support brand planning, new product planning, and input into clinical development • Act as the commercial voice on cross-functional product teams for programs in development. Integrate with Medical Affairs, Regulatory, Market Access, Commercial Analytics, Finance, and Business Development
• Education and Experience • - Bachelor’s degree required in Marketing, Business, Life Sciences, or a related field • - 10+ years of progressive experience in pharmaceutical or biotechnology commercial roles • - Significant experience in strategic marketing, commercial strategy, brand management, and/or new product planning • - Experience in rare disease, especially Pulmonary Hypertension, is a plus • Knowledge, Skills, and Abilities • - Deep understanding of pharmaceutical commercialization, including brand strategy, lifecycle management, new product planning • - Strong understanding of clinical development processes, evidence-generation strategies, labeling considerations, and regulatory pathways. • - Analytical and insights capabilities—proficiency in interpreting qualitative and quantitative market research, competitive intelligence, and performance analytics • - Financial acumen—comfort with forecasting models, scenario planning, and business case development for lifecycle or pipeline investments • - Ability to thrive in small company environment
• Liquidia offers a competitive compensation package as well as a comprehensive benefits package that includes Medical, Dental, Vision, STD, LTD, 401(k) Savings Retirement Plan, ESPP, and more!
Candidatar-se🕒 Julho 27
Executive Director responsible for organizational leadership and fundraising at Keep A Child Alive. Focus on program execution and strategic partnerships for a high-impact global nonprofit.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Director of Employee Health and Safety providing leadership in START's Oncology Clinical Research. Ensuring operational safety and compliance, engaging in multi-site EHS initiatives and training.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Director overseeing a team of Field Reimbursement Managers, ensuring strategic direction in reimbursement strategies. Collaborating with healthcare providers and payers for optimal product access.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Director of Corporate Partnership Engagement responsible for sourcing and executing offtake opportunities with corporate buyers. Supporting energy solutions across solar, battery storage, and gas generation sectors.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Agentic Workspace Solution Director at Genpact designing Microsoft-based solutions for modern workspaces. Leading projects and sales enablement with a focus on employee experience and productivity.
🗣️🇺🇸🇬🇧 Inglês obrigatório